FENI vs JIRE
Fidelity Enhanced International ETF vs JPMorgan International Research Enhanced Equity ETF
Which is better, FENI or JIRE?
Nearly the same fund. JIRE costs less.
JIRE has a lower expense ratio. FENI led over 1Y, 3Y and the full window. The two have moved almost in lockstep, correlation 0.98. FENI is less concentrated, with 15.8% of the fund in its ten largest positions against 16.7%.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | FENI | JIRE |
|---|---|---|
| Expense Ratio | 0.28% | 0.24%Best |
| AUM | $11.5B | $11.0B |
| Dividend Yield | 3.05% | 2.73% |
| Holdings | 883 | 216 |
| YTD Return | +8.98%Best | +7.25% |
| 1Y Return | +15.83%Best | +13.67% |
| 3Y Return (annualized) | +20.24%Best | +17.60% |
| Volatility (annualized) | 11.6% | 11.4%Best |
| Max Drawdown | -14.2% | -13.6%Best |
| $10,000 over 2.9 years | $17,066Best | $15,568 |
| Top 10 Weight | 15.8%Best | 16.7% |
| Fund Family | Fidelity Investments (US) | J.P. Morgan Asset Management |
| Category | Equity | Equity |
| Style | Large Cap Blend | Large Cap Blend |
| Inception | Nov 20, 2023 | Jun 10, 2022 |
Not shown on this pair: 5Y Return (annualized).
Volatility and max drawdown, and the $10,000 over 2.9 years row, are measured over the window both funds cover: Nov 20, 2023 to Oct 14, 2026 (2.9 years).
FENI vs JIRE growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 2.9 years both funds cover.
FENI vs JIRE Performance
Fidelity Enhanced International ETF (FENI) is an ETF from Fidelity Investments (US) and JPMorgan International Research Enhanced Equity ETF (JIRE) is an ETF from J.P. Morgan Asset Management. Over the past year FENI returned +15.83% while JIRE returned +13.67%. Year to date, FENI is up 8.98% versus a gain of 7.25% for JIRE.
Over three years, FENI compounded at +20.24% per year against +17.60% for JIRE.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
FENI has been the more volatile fund, with annualized monthly volatility of 11.6% compared with 11.4% for JIRE. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -14.2% for FENI and -13.6% for JIRE. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.98. They move almost in lockstep, so holding both mostly duplicates the same exposure.
Fees and Cost Over Time
FENI charges 0.28% per year while JIRE charges 0.24%. On a $10,000 position that is $28 vs $24 annually, a gap of $4 per year that compounds over a long holding period. On income, FENI currently yields 3.05% against 2.73% for JIRE.
Holdings Overlap
48.8% of FENI's money is in holdings JIRE also owns. 60.1% of JIRE's money is in holdings FENI also owns.
The two portfolios partly overlap.
111 positions in common, counted across the 423 positions we hold weights for in FENI and 206 in JIRE, against full books of 883 and 216.
What only one of them owns
Our book lists 3 positions for JIRE that do not appear in our book for FENI (2.9% of the fund), and 0 for FENI that do not appear in JIRE (0.9%).
Some of those will be the same company recorded under a different code in one of the two books, so the real difference in what you would own is no larger than this and may be smaller. We do not name the individual positions here for that reason.
Top Shared Holdings
| Stock | Weight in FENI | Weight in JIRE | Difference |
|---|---|---|---|
| ASML:ASAsml Holding Nv Unsponsored Adr Ordinary Shares | 3.58% | 3.82% | 0.24% |
| SIE:SGSiemens Ag Reg Common Stock | 1.51% | 1.73% | 0.22% |
| ROP:SMRoche Holding Ag /Chf/ 0.00000000 | 1.59% | 1.29% | 0.30% |
| NESN:SMNestle Sa | 1.52% | 1.25% | 0.27% |
| HSBA:LNHsbc Holdings Plc | 1.07% | 1.47% | 0.40% |
| 8035:JPTokyo Electron Ltd. Com Stk | 1.38% | 1.12% | 0.26% |
| NOVN:SMNovartis AG | 1.28% | 1.15% | 0.13% |
| 6857:JPAdvantest Corp | 1.43% | 0.99% | 0.44% |
| AZN:LNAstraZeneca PLC | 0.67% | 1.65% | 0.98% |
| 6098:TKRecruit Holdings Co Ltd | 1.17% | 1.08% | 0.09% |
60.1% of JIRE is already inside FENI.
You probably hold more than these two. Add the rest and see how much of the whole book is the same companies twice.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, FENI or JIRE?
FENI has an expense ratio of 0.28% while JIRE charges 0.24%. JIRE is the cheaper option, by $4 a year on a $10,000 investment.
Which performed better, FENI or JIRE?
Over the past year FENI returned +15.83% vs +13.67% for JIRE, so FENI leads on 1-year performance. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, FENI or JIRE?
FENI has been the more volatile fund at 11.6% annualized versus 11.4% for JIRE. Worst drawdown: FENI -14.2% vs JIRE -13.6%.
Should I hold both FENI and JIRE?
FENI and JIRE have a monthly-return correlation of 0.98, so they move almost identically. What is left to separate them is the fee and the index each one tracks. This is information, not a recommendation.
What is the holdings overlap between FENI and JIRE?
60.1% of JIRE's money is in holdings FENI also owns. 60.1% of JIRE's is in holdings FENI also owns. They hold 111 positions in common, counted across the 423 positions we hold weights for in FENI and 206 in JIRE.
Which pays a higher dividend, FENI or JIRE?
FENI yields 3.05% while JIRE yields 2.73%, so FENI currently pays the higher dividend yield.
Is JIRE better than FENI?
JIRE has a lower expense ratio. FENI led over 1Y, 3Y and the full window. The two have moved almost in lockstep, correlation 0.98. FENI is less concentrated, with 15.8% of the fund in its ten largest positions against 16.7%. Which one suits a particular account depends on what it is for. This is information, not a recommendation.